Our Backbone: Cancer Centres

The backbone of the 3CTN initiative are the member sites that collaborate and communicate via our innovative Network structure.

EXPLORE THE NETWORK

Our Voice: Patient Representatives

Patient Representatives can contribute a crucial perspective to clinical trials by providing feedback, insight, expertise and support towards trial activities and initiatives.

LEARN ABOUT OUR PATIENT REPRESENTATIVE COMMUNITY

Coordinating Centre

At the pinnacle of the Network, The 3CTN Coordinating Centre acts as the leadership and communication hub for the Network and is responsible for supporting and coordinating activities at the Network sites, in order to reach the Network’s goals and objectives.

Janet Dancey, MD
Scientific Director

Bernie Eigl, MD
Associate Scientific Director

Gerald Batist, MD
Associate Scientific Director

Stephen Sundquist
Executive Director

Lam Pho
Director, Information Technology

Diana Kato
Manager, Operations

Rebecca Xu
Manager, Portfolio and Informatics

James Schoales
Portfolio Data Analyst

Raisa Chowdhury
Project Coordinator

Our Governance

Each committee in our governance brings expert knowledge at a high level, which is crucial to the success of 3CTN as it provides a link to the broader Canadian cancer research environment with the aim of maintaining 3CTN’s relevance and sustainability.

Scientific Advisory Board

David Cameron, MD (Chair)
Chair, Breast International Group

Gavin Stuart, MD
Professor, Division of Gynecologic Oncology, University of British Columbia

Judy Needham
Patient Representative

Rachel Syme, Ph.D
Assistant Director, Institute of Cancer Research, Canadian Institutes of Health Research

Stephen Sundquist
Executive Director, 3CTN

Janet Dancey, MD
Scientific Director, 3CTN

Funders Oversight Committee

Sara Urowitz (Chair)
Executive Director, Canadian Cancer Research Alliance

Christy Holtby
Vice President, Philanthropy, Alberta Cancer Foundation

Liam Kelly
Regional Director of Research and Innovation, Eastern Regional Health Authority

Lynette Hillier
Executive Director, Dr. H. Bliss Murphy Cancer Care Foundation

Gerald Batist, MD
Scientific Director, Q-Clinical Research Organization in Cancer (Q-CROC)

Bernie Eigl, MD
Provincial Director, Systemic Therapy Clinical Trials, BC Cancer Agency

Antonia Palmer
Patient Representative

Christine Williams, PhD
Deputy Director and Head, Clinical Translation, Ontario Institute for Cancer Research

Janet Dancey, MD
Scientific Director, 3CTN

Stephen Sundquist
Executive Director, 3CTN

Joseph Pater, MSc, MD
Emeritus Professor, Queen’s University

Management and Executive (*) Committee

Joseph Pater, MSc, MD (Chair)
Emeritus Professor, Queen’s University

Bernie Eigl*, MD
Provincial Director, Systemic Therapy Clinical Trials, BC Cancer Agency

Rosalyn Juergens, MD, Ph.D
Head of the Department of Clinical Trials, Juravinski Cancer Centre

Gerald Batist*, MD
Scientific Director, Q-Clinical Research Organization in Cancer (Q-CROC)

Joel Gingerich, MD
Medical Director, Community Oncology, CancerCare Manitoba

John Thoms, MD
Physician Director, Clinical Trials, Dr. H. Bliss Murphy Cancer Centre

Rosalyn Juergens, MD, Ph.D
Head of the Department of Clinical Trials, Juravinski Cancer Centre

Jim Pankovich
Vice President, Clinical Operations & Drug Development, Qu Biologics

Patricia Tang, MD
Clinical Assistant Professor, Department of Oncology, Tom Baker Cancer Centre

Jim Whitlock, MD
Division Head, Haematology/Oncology, The Hospital for Sick Children

Chantale Thurston
Patient Representative

Don Wood
Patient Representative

Lam Pho
Director, Information Technology, 3CTN

Janet Dancey*, MD
Scientific Director, 3CTN

Stephen Sundquist
Executive Director, 3CTN

Our Operating/Advisory Committees

Portfolio Sub-Committee

This team is responsible for reviewing the criteria for trial entry into the Portfolio and metrics for trial retention within the Portfolio; and reviewing the trial Portfolio for scientific merit, priority, performance and strategic balance to cover the range of trials of interest/relevance to Canadians and the Canadian health care system.

Joseph Pater, MSc, MD (Chair)
Emeritus Professor, Queen’s University

Jim Wright, MD
Radiation Oncologist, Juravinski Cancer Centre

Janet Dancey, MD
Scientific Director, 3CTN

Stephen Sundquist
Executive Director

Rebecca Xu
Manager, Portfolio and Informatics

James Schoales
Portfolio Data Analyst

Performance Strategy Sub-Committee

This team is responsible for evaluating Network performance, identifying problems and proposing new initiatives, tools to improve the efficiency and quality of trial activities, improvements to and competencies of clinical trial staff through education, training and mentoring and greater patient access to trials.

Brenda Kowaleski (Chair)
Clinical Trials Manager, Juravinski Cancer Centre

Lynn Dwernychuk
Director, Clinical Research, Saskatchewan Cancer Agency

Dora Nomikos
Manager, Trial Management Group, Canadian Cancer Trials Group

Carla Girolametto
Director, Innovation and Research and Clinical Trials, Grand River Hospital

Christine Samara
Manager, Quality Assurance and Education, Odette Cancer Centre Clinical Research Program

Stephen Sundquist
Executive Director, 3CTN

Patient Representative Advisory Sub-Committee

The PRAC is a team of 3CTN Patient Representatives and 3CTN CC staff with the focus of providing feedback, insight, expertise and support to the Network.

Don Wood (Chair)
Alberta

Gretta Hutton
Ontario

Louise Gagne
Quebec

Jean-Francois Denault
Quebec

Stephanie Mayne
Newfoundland

Alison Stoneman
Ontario

Emily Piercell
Ontario

Amy Clark
Manitoba

Stephen Sundquist
Executive Director, 3CTN

Our Partners

Our Canada-wide initiative is made possible by contributions from our funders and through collaborations with organizations who share our vision for the cancer clinical trial landscape.

Funding Partners

Collaborators

CONTACT US ABOUT PARTNERSHIPS